Real-world study on adoption of standard-of-care for transplant-eligible newly diagnosed multiple myeloma patients between 2017 and 2020/2021 across France, Germany, Spain, and Italy.
Katja WeiselAstrid Ottosson WadlundGuntug GungorEileen DergarabetianCécile PachecoNihar MasurkarPaula Rodriguez-OteroPublished in: European journal of haematology (2022)
The use of bortezomib triplets in induction varied markedly over time and between selected countries.